Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05664893
Title Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS) (CALHYS)
Acronym CALHYS
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Centre Antoine Lacassagne
Indications
Therapies
Age Groups: senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Antoine Lacassagne RECRUITING Nice 06189 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field